Pradaxa linked with excessive bleeding deaths, studies continue

The anticoagulant medication Pradaxa continues to be linked to excessive bleeding and other fatal side effects. Known generically as dabigatran, the medication is used to prevent strokes in patients who suffer from atrial fibrillation and are at higher risk for suffering from strokes.

However, Pradaxa has been linked to an increased risk of bleeding, and according to the medication's maker, there were reportedly 260 reports of fatal bleeding worldwide associated with Pradaxa use.

The Archives of Internal Medicine published a study in 2012 suggesting a link between the use of Pradaxa and a higher risk of heart attack or acute coronary syndrome when compared with similar medicines such as warfarin, enoxaparin and a placebo.

Prior to these findings, the FDA made an announcement saying it believed Pradaxa offers an important medical benefit. Now, further studies are being done to determine whether the increased risk of heart attacks in patients who take Pradaxa outweigh the benefits of the medication.

If you or a loved one has suffered personal damages from the use of Pradaxa or its generic version dabigatran, simply click the link at the bottom of the page and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.